ES538032A0 - Un procedimiento para preparar derivados de isoxazolamina. - Google Patents

Un procedimiento para preparar derivados de isoxazolamina.

Info

Publication number
ES538032A0
ES538032A0 ES538032A ES538032A ES538032A0 ES 538032 A0 ES538032 A0 ES 538032A0 ES 538032 A ES538032 A ES 538032A ES 538032 A ES538032 A ES 538032A ES 538032 A0 ES538032 A0 ES 538032A0
Authority
ES
Spain
Prior art keywords
isoxazolamine
derivatives
preparing
procedure
preparing isoxazolamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES538032A
Other languages
English (en)
Other versions
ES8601936A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of ES8601936A1 publication Critical patent/ES8601936A1/es
Publication of ES538032A0 publication Critical patent/ES538032A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES538032A 1983-03-23 1984-11-28 Un procedimiento para preparar derivados de isoxazolamina. Granted ES538032A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47801683A 1983-03-23 1983-03-23
US06/575,411 US4489077A (en) 1983-03-23 1984-02-02 3-Isoxa-zolyl-2H-1,2-benzothiazine-3-carboxamide, 1,1-dioxides

Publications (2)

Publication Number Publication Date
ES8601936A1 ES8601936A1 (es) 1985-11-01
ES538032A0 true ES538032A0 (es) 1985-11-01

Family

ID=27045759

Family Applications (2)

Application Number Title Priority Date Filing Date
ES530855A Granted ES530855A0 (es) 1983-03-23 1984-03-22 Un procedimiento para preparar derivados de benzotiazina
ES538032A Granted ES538032A0 (es) 1983-03-23 1984-11-28 Un procedimiento para preparar derivados de isoxazolamina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES530855A Granted ES530855A0 (es) 1983-03-23 1984-03-22 Un procedimiento para preparar derivados de benzotiazina

Country Status (8)

Country Link
US (1) US4489077A (es)
EP (1) EP0123418B1 (es)
AU (1) AU562834B2 (es)
CA (1) CA1229599A (es)
DE (1) DE3468876D1 (es)
DK (1) DK118884A (es)
ES (2) ES530855A0 (es)
GR (1) GR81482B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030063046A (ko) * 2002-01-22 2003-07-28 주식회사 엘지생명과학 엘비84068을 함유하는 염증으로 인한 질환의 예방 및치료용 조성물 및 이를 포함하는 제제
DOP2003000641A (es) * 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
KR100568191B1 (ko) * 2002-08-22 2006-04-07 서홍석 4-[(알킬설판일)메틸]-1,2-벤젠디올 유도체, 이의제조방법 및 이를 포함하는 항산화제
US7148226B2 (en) * 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
UA88909C2 (ru) * 2004-08-18 2009-12-10 Пфайзер Инк. Ингибиторы рнк-зависимой рнк-полимеразы вируса гепатита с, фармацевтическая композиция на их основе и их применение

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3787324A (en) * 1971-03-01 1974-01-22 Warner Lambert Co 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production
US3868367A (en) * 1974-04-11 1975-02-25 Warner Lambert Co 4-Hydroxy-3-(5-isoxazolylcarbamoyl)-2H-1,2-benzothiazine 1,1-dioxides
FI832754A7 (fi) * 1982-08-09 1984-02-10 Ppg Industries Inc Menetelmä 3-amino-5- (substituoitu)isoksatsolin valmistamiseksi.

Also Published As

Publication number Publication date
EP0123418B1 (en) 1988-01-20
GR81482B (es) 1984-12-11
DK118884A (da) 1984-09-24
ES8601936A1 (es) 1985-11-01
US4489077A (en) 1984-12-18
AU2514984A (en) 1984-09-27
AU562834B2 (en) 1987-06-18
EP0123418A1 (en) 1984-10-31
ES8506307A1 (es) 1985-07-01
DE3468876D1 (en) 1988-02-25
DK118884D0 (da) 1984-02-28
ES530855A0 (es) 1985-07-01
CA1229599A (en) 1987-11-24

Similar Documents

Publication Publication Date Title
ES543732A0 (es) Un procedimiento para preparar derivados de aminoalquilfenaxi.
ES538721A0 (es) Un procedimiento para preparar derivados de guanina
ES538190A0 (es) Un procedimiento para preparar derivados de pirimidina
ES553613A0 (es) Un procedimiento para preparar derivados de alanil-prolina.
ES538518A0 (es) Un procedimiento para preparar derivados de 3-aminopirazolo-(3,4-d)-pirimidina
ES537104A0 (es) Un procedimiento para preparar derivados de tiazina
ES538238A0 (es) Un procedimiento para preparar derivados de adenosina.
ES527994A0 (es) Un procedimiento para preparar derivados de piridina.
ES530391A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
ES535568A0 (es) Un procedimiento para preparar derivados de piridazinona
ES555009A0 (es) Un procedimiento para preparar derivados de 3-hidroxibutanamido-acetato.
ES527304A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES520709A0 (es) Un procedimiento para preparar derivados de piridina.
ES521955A0 (es) Un procedimiento para preparar derivados de cefalosporina.
ES519936A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES538036A0 (es) Un procedimiento para preparar derivados de piridona.
ES536864A0 (es) Un procedimiento para preparar derivados de azetidina sustituidos.
ES522716A0 (es) Un procedimiento para preparar un derivado de pirazol.
ES541598A0 (es) Un procedimiento para preparar derivados de isoquinolina.
ES508928A0 (es) Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos.
ES538032A0 (es) Un procedimiento para preparar derivados de isoxazolamina.
ES529478A0 (es) Un procedimiento para preparar derivados de mitomicina
ES506930A0 (es) Un procedimiento para preparar derivados de n-fenil-dicloro-maleimida.
ES513399A0 (es) Un procedimiento para preparar derivados de dialcohilpirazol
ES538037A0 (es) Un procedimiento para preparar derivados de pirazinona.